4WM
EW icon

49 Wealth Management’s Edwards Lifesciences EW Stock Holding History

49 Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
+3,966
New +$332K 0.07% 126

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

49 Wealth Management's EW Position: Q2 2026 in Review

49 Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,966 shares worth $359K. The stake represents 0.07% of the portfolio and ranks #126 among its holdings.

1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • 49 Wealth Management held 3,966 shares of Edwards Lifesciences worth $359K as of Q2 2026.
  • Edwards Lifesciences was a new 49 Wealth Management position in Q2 2026.
  • Edwards Lifesciences made up 0.07% of 49 Wealth Management's portfolio in Q2 2026, its #126 holding.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.